Tolvaptan 90mg tablets and Tolvaptan 30mg tablets
NHS hospitals in England used £18,413,814 of indicative cost of Tolvaptan 90mg tablets and Tolvaptan 30mg tablets in the 12 months to July 2026, about 0.1% of all hospital medicines spend. That is up 11.6% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Tolvaptan 90mg tablets and Tolvaptan 30mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Tolvaptan 90mg tablets and Tolvaptan 30mg tablets most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Royal Free London Nhs Foundation Trust | £1,265,710 |
| Barts Health Nhs Trust | £1,177,391 |
| Salford Royal Nhs Foundation Trust | £751,863 |
| London North West Healthcare Nhs Trust | £736,277 |
| Western Sussex Hospitals Nhs Found Trust | £712,437 |
| Southend Univ Hosp Nhs Foundation Trust | £647,146 |
| Imperial College Healthcare Nhs Trust | £611,470 |
| Lancashire T/Ing Hsp Nhs Foundation Trus | £557,463 |
| Oxford University Hospitals Nhs Ft | £531,850 |
| Aintree University Hospital Nhs Ft | £497,174 |
The primary-care picture
Tolvaptan is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Tolvaptan medicine page.